Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05547061
What this trial is testing

A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy

Who this might be right for
Prostate CancermCRPC
Cellbion Co., Ltd. 91
Early research (Phase 1)Ended earlyNCT01420952
What this trial is testing

Imaging of Brain Receptors Using (11C)mGlu1

Who this might be right for
DosimetryPharmacokinetics
National Institute of Mental Health (NIMH) 3
Testing effectiveness (Phase 2)Looking for participantsNCT07070349
What this trial is testing

A Trial of HRS-6213 in Healthy Subjects and Patients With Solid Tumors

Who this might be right for
Patients With Solid Tumors
Jiangsu HengRui Medicine Co., Ltd. 48
Early research (Phase 1)Study completedNCT00954538
What this trial is testing

Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 19
Testing effectiveness (Phase 2)WithdrawnNCT03013387
What this trial is testing

Dosimetry Guided PRRT With 90Y-DOTATOC

Who this might be right for
Neuroendrocrine TumorsMeningiomaNeuroblastoma+1 more
Sue O'Dorisio
Not applicableLooking for participantsNCT07380204
What this trial is testing

Quantification of Hsp90 in the Human Brain

Who this might be right for
Parkinson's Disease (PD)Alzheimer's Disease (AD)Amyotrophic Lateral Sclerosis (ALS)
Universitaire Ziekenhuizen KU Leuven 48
Not applicableEnded earlyNCT02279693
What this trial is testing

Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Centre Georges Francois Leclerc 3
Very early researchLooking for participantsNCT07459283
What this trial is testing

The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

Who this might be right for
Maligant Solid TumorHead & Neck CancerThyroid Cancer+3 more
FindCure Biosciences (ZhongShan) Co., Ltd. 10
Early research (Phase 1)Looking for participantsNCT07600554
What this trial is testing

A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer

Who this might be right for
Prostate Cancer
Philogen S.p.A. 20
Not applicableNot Yet RecruitingNCT07587814
What this trial is testing

Impact of Body Composition on Dosimetry of 177Lu-PSMA Radioligand Therapy

Who this might be right for
CarcinomaCastration Resistant Prostatic Neoplasms
Centre Henri Becquerel 100
Post-approval studies (Phase 4)Study completedNCT00001730
What this trial is testing

Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.

Who this might be right for
HypothyroidismThyroid Neoplasms
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 20
Early research (Phase 1)Study completedNCT03183544
What this trial is testing

Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit

Who this might be right for
Prostatic Neoplasm
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 3
Not applicableStudy completedNCT02658513
What this trial is testing

Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer

Who this might be right for
Cancer of the ThyroidCancer of ThyroidThyroid Cancer+1 more
Royal Surrey County Hospital NHS Foundation Trust 35
Not applicableStudy completedNCT05223946
What this trial is testing

Treatment and Companion Diagnostics of Lower Back Pain Using SCENAR and Passive Medical Radiometry (MWR)

Who this might be right for
Low Back Pain, Recurrent
Kyrgyz State Medical Academy 55
Not applicableStudy completedNCT04568525
What this trial is testing

Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs

Who this might be right for
Covid19
Kyrgyz State Medical Academy 195
Very early researchEnded earlyNCT06516510
What this trial is testing

A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Blue Earth Therapeutics Ltd 17
Not applicableEnded earlyNCT06302400
What this trial is testing

Individualized Dosimetry for Holmium-166 Radioembolization in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Imperial College London 4
Very early researchLooking for participantsNCT07774650
What this trial is testing

The Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers

Who this might be right for
Healthy Volunteer
Ratio Therapeutics, Inc. 12
Very early researchNot Yet RecruitingNCT05557708
What this trial is testing

A Safety Study of 212Pb-Pentixather Radioligand Therapy

Who this might be right for
Carcinoid Tumor LungNeuroendocrine Tumor of the LungCarcinoma, Small-Cell Lung
Yusuf Menda 20
Not applicableStudy completedNCT04296617
What this trial is testing

Brain Imaging Changes Following Proton Therapy for Pediatric Primary Central Nervous System and Base of Skull Tumors

Who this might be right for
Malignant Central Nervous System NeoplasmMalignant Skull Base Neoplasm
Mayo Clinic 36
Next Page